SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-06-226363
Filing Date
2006-11-07
Accepted
2006-11-07 13:15:33
Documents
5
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 586316
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9208
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9196
4 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2667
5 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2649
  Complete submission text file 0001193125-06-226363.txt   611459
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27570 | Film No.: 061193053
SIC: 8731 Services-Commercial Physical & Biological Research